Study to Identify and Characterize Adults with Type 2 Diabetes for Participation in Ongoing or Future Clinical Trials

What this Trial Is About

This observational study focuses on adults with Type 2 Diabetes Mellitus T2DM who are evaluated to identify and describe their condition and treatment patterns. The study aims to better understand patients with T2DM, particularly those whose diabetes management is not fully controlled by lifestyle changes or stable glucose-lowering medications. AstraZeneca sponsors this study to help link patients to ongoing or future T2DM clinical trials. Participants with T2DM will undergo assessments including blood sample collection about 2 mL and evaluation of medical history, medication use, and HbA1c blood sugar levels. The study involves a single visit where these data are collected to characterize patient demographics and treatment trends. Those interested and willing to participate may be referred to other relevant T2DM studies based on these findings. During the single study visit, participants provide informed consent and undergo blood sampling and questionnaires about their health and medication use. Researchers measure HbA1c levels and document medical and surgical histories. The main outcomes include demographic information, medication usage patterns, and the potential referral of participants to future T2DM trials. The entire participation lasts only one day, focusing on capturing detailed baseline information.

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies